A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia

Published:2015-03 Issue:2 Volume:1 Page:1-7
ISSN:2373-8731
Container-title:Transplantation Direct
language:en
Short-container-title:

Author:

Shigematsu Akio,Ozawa Yukiyasu,Onizuka Makoto,Fujisawa Shin,Suzuki Ritsuro,Atsuta Yoshiko,Hatanaka Kazuo,Masuko Masayoshi,Ito Toshiro,Kobayashi Naoki,Kato Jun,Miyamura Koichi,Fukuda Takahiro,Morishima Yasuo,Imamura Masahiro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference33 articles.

1. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults.;Hoelzer;Blood,1988

2. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.;Kantarjian;J Clin Oncol,2000

3. Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study.;Annino;Blood,2002

4. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XIIECOG E2993.;Rowe;Blood,2005

5. For the Adult Leukaemia Working Party, Medical Research CouncilNational Cancer Research Institute. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXIIEastern Cooperative Oncology Group (ECOG) 2993 trial.;Moorman;Blood,2007

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medium-dose etoposide, cyclophosphamide and total body irradiation conditioning potentiates anti-leukemia immunity in adults with acute lymphoblastic leukemia without aggravating graft-versus-host disease;Cytotherapy;2023-12

2. Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults;Cytotherapy;2022-09

3. Adult patients with Ph+ ALL benefit from conditioning regimen of medium‐dose VP16 plus CY/TBI;Hematological Oncology;2022-07-10

4. Total Body Irradiation–Based Conditioning Regimen Improved the Survival of Adult Patients With T-Cell Lymphoblastic Lymphoma After Allogeneic Peripheral Blood Stem Cell Transplantation;Cell Transplantation;2022-01

5. Phase 1 study of plerixafor in combination with total body irradiation-based myeloablative conditioning for allogeneic hematopoietic stem cell transplantation;International Journal of Hematology;2021-03-01